Public Act 096-1353 Public Act 1353 96TH GENERAL ASSEMBLY |
Public Act 096-1353 | HB5890 Enrolled | LRB096 18739 ASK 34124 b |
|
| AN ACT concerning regulation.
| Be it enacted by the People of the State of Illinois,
| represented in the General Assembly:
| Section 5. The Pharmacy Practice Act is amended by changing | Section 3 as follows:
| (225 ILCS 85/3)
| (Text of Section before amendment by P.A. 96-339 ) | (Section scheduled to be repealed on January 1, 2018)
| Sec. 3. Definitions. For the purpose of this Act, except | where otherwise
limited therein:
| (a) "Pharmacy" or "drugstore" means and includes every | store, shop,
pharmacy department, or other place where | pharmacist
care is
provided
by a pharmacist (1) where drugs, | medicines, or poisons are
dispensed, sold or
offered for sale | at retail, or displayed for sale at retail; or
(2)
where
| prescriptions of physicians, dentists, advanced practice | nurses, physician assistants, veterinarians, podiatrists, or
| optometrists, within the limits of their
licenses, are
| compounded, filled, or dispensed; or (3) which has upon it or
| displayed within
it, or affixed to or used in connection with | it, a sign bearing the word or
words "Pharmacist", "Druggist", | "Pharmacy", "Pharmaceutical
Care", "Apothecary", "Drugstore",
| "Medicine Store", "Prescriptions", "Drugs", "Dispensary", |
| "Medicines", or any word
or words of similar or like import, | either in the English language
or any other language; or (4) | where the characteristic prescription
sign (Rx) or similar | design is exhibited; or (5) any store, or
shop,
or other place | with respect to which any of the above words, objects,
signs or | designs are used in any advertisement.
| (b) "Drugs" means and includes (l) articles recognized
in | the official United States Pharmacopoeia/National Formulary | (USP/NF),
or any supplement thereto and being intended for and | having for their
main use the diagnosis, cure, mitigation, | treatment or prevention of
disease in man or other animals, as | approved by the United States Food and
Drug Administration, but | does not include devices or their components, parts,
or | accessories; and (2) all other articles intended
for and having | for their main use the diagnosis, cure, mitigation,
treatment | or prevention of disease in man or other animals, as approved
| by the United States Food and Drug Administration, but does not | include
devices or their components, parts, or accessories; and | (3) articles
(other than food) having for their main use and | intended
to affect the structure or any function of the body of | man or other
animals; and (4) articles having for their main | use and intended
for use as a component or any articles | specified in clause (l), (2)
or (3); but does not include | devices or their components, parts or
accessories.
| (c) "Medicines" means and includes all drugs intended for
| human or veterinary use approved by the United States Food and |
| Drug
Administration.
| (d) "Practice of pharmacy" means (1) the interpretation and | the provision of assistance in the monitoring, evaluation, and | implementation of prescription drug orders; (2) the dispensing | of prescription drug orders; (3) participation in drug and | device selection; (4) drug administration limited to the | administration of oral, topical, injectable, and inhalation as | follows: in the context of patient education on the proper use | or delivery of medications; vaccination of patients 14 years of | age and older pursuant to a valid prescription or standing | order, by a physician licensed to practice medicine in all its | branches, upon completion of appropriate training, including | how to address contraindications and adverse reactions set | forth by rule, with notification to the patient's physician and | appropriate record retention, or pursuant to hospital pharmacy | and therapeutics committee policies and procedures; (5) drug | regimen review; (6) drug or drug-related research; (7) the | provision of patient counseling; (8) the practice of | telepharmacy; (9) the provision of those acts or services | necessary to provide pharmacist care; (10) medication therapy | management; and (11) the responsibility for compounding and | labeling of drugs and devices (except labeling by a | manufacturer, repackager, or distributor of non-prescription | drugs and commercially packaged legend drugs and devices), | proper and safe storage of drugs and devices, and maintenance | of required records. A pharmacist who performs any of the acts |
| defined as the practice of pharmacy in this State must be | actively licensed as a pharmacist under this Act.
| (e) "Prescription" means and includes any written, oral, | facsimile, or
electronically transmitted order for drugs
or | medical devices, issued by a physician licensed to practice | medicine in
all its branches, dentist, veterinarian, or | podiatrist, or
optometrist, within the
limits of their | licenses, by a physician assistant in accordance with
| subsection (f) of Section 4, or by an advanced practice nurse | in
accordance with subsection (g) of Section 4, containing the
| following: (l) name
of the patient; (2) date when prescription | was issued; (3) name
and strength of drug or description of the | medical device prescribed;
and (4) quantity ; , (5) directions | for use ; , (6) prescriber's name,
address ,
and signature ; , and | (7) DEA number where required, for controlled
substances . The | prescription may, but is not required to, list the illness, | disease, or condition for which the drug or device is being | prescribed .
DEA numbers shall not be required on inpatient drug | orders.
| (f) "Person" means and includes a natural person, | copartnership,
association, corporation, government entity, or | any other legal
entity.
| (g) "Department" means the Department of Financial and
| Professional Regulation.
| (h) "Board of Pharmacy" or "Board" means the State Board
of | Pharmacy of the Department of Financial and Professional |
| Regulation.
| (i) "Secretary"
means the Secretary
of Financial and | Professional Regulation.
| (j) "Drug product selection" means the interchange for a
| prescribed pharmaceutical product in accordance with Section | 25 of
this Act and Section 3.14 of the Illinois Food, Drug and | Cosmetic Act.
| (k) "Inpatient drug order" means an order issued by an | authorized
prescriber for a resident or patient of a facility | licensed under the
Nursing Home Care Act or the Hospital | Licensing Act, or "An Act in relation to
the founding and | operation of the University of Illinois Hospital and the
| conduct of University of Illinois health care programs", | approved July 3, 1931,
as amended, or a facility which is | operated by the Department of Human
Services (as successor to | the Department of Mental Health
and Developmental | Disabilities) or the Department of Corrections.
| (k-5) "Pharmacist" means an individual health care | professional and
provider currently licensed by this State to | engage in the practice of
pharmacy.
| (l) "Pharmacist in charge" means the licensed pharmacist | whose name appears
on a pharmacy license and who is responsible | for all aspects of the
operation related to the practice of | pharmacy.
| (m) "Dispense" or "dispensing" means the interpretation, | evaluation, and implementation of a prescription drug order, |
| including the preparation and delivery of a drug or device to a | patient or patient's agent in a suitable container | appropriately labeled for subsequent administration to or use | by a patient in accordance with applicable State and federal | laws and regulations.
"Dispense" or "dispensing" does not mean | the physical delivery to a patient or a
patient's | representative in a home or institution by a designee of a | pharmacist
or by common carrier. "Dispense" or "dispensing" | also does not mean the physical delivery
of a drug or medical | device to a patient or patient's representative by a
| pharmacist's designee within a pharmacy or drugstore while the | pharmacist is
on duty and the pharmacy is open.
| (n) "Nonresident pharmacy"
means a pharmacy that is located | in a state, commonwealth, or territory
of the United States, | other than Illinois, that delivers, dispenses, or
distributes, | through the United States Postal Service, commercially | acceptable parcel delivery service, or other common
carrier, to | Illinois residents, any substance which requires a | prescription.
| (o) "Compounding" means the preparation and mixing of | components, excluding flavorings, (1) as the result of a | prescriber's prescription drug order or initiative based on the | prescriber-patient-pharmacist relationship in the course of | professional practice or (2) for the purpose of, or incident | to, research, teaching, or chemical analysis and not for sale | or dispensing. "Compounding" includes the preparation of drugs |
| or devices in anticipation of receiving prescription drug | orders based on routine, regularly observed dispensing | patterns. Commercially available products may be compounded | for dispensing to individual patients only if all of the | following conditions are met: (i) the commercial product is not | reasonably available from normal distribution channels in a | timely manner to meet the patient's needs and (ii) the | prescribing practitioner has requested that the drug be | compounded.
| (p) (Blank).
| (q) (Blank).
| (r) "Patient counseling" means the communication between a | pharmacist or a student pharmacist under the supervision of a | pharmacist and a patient or the patient's representative about | the patient's medication or device for the purpose of | optimizing proper use of prescription medications or devices. | "Patient counseling" may include without limitation (1) | obtaining a medication history; (2) acquiring a patient's | allergies and health conditions; (3) facilitation of the | patient's understanding of the intended use of the medication; | (4) proper directions for use; (5) significant potential | adverse events; (6) potential food-drug interactions; and (7) | the need to be compliant with the medication therapy. A | pharmacy technician may only participate in the following | aspects of patient counseling under the supervision of a | pharmacist: (1) obtaining medication history; (2) providing |
| the offer for counseling by a pharmacist or student pharmacist; | and (3) acquiring a patient's allergies and health conditions.
| (s) "Patient profiles" or "patient drug therapy record" | means the
obtaining, recording, and maintenance of patient | prescription
information, including prescriptions for | controlled substances, and
personal information.
| (t) (Blank).
| (u) "Medical device" means an instrument, apparatus, | implement, machine,
contrivance, implant, in vitro reagent, or | other similar or related article,
including any component part | or accessory, required under federal law to
bear the label | "Caution: Federal law requires dispensing by or on the order
of | a physician". A seller of goods and services who, only for the | purpose of
retail sales, compounds, sells, rents, or leases | medical devices shall not,
by reasons thereof, be required to | be a licensed pharmacy.
| (v) "Unique identifier" means an electronic signature, | handwritten
signature or initials, thumb print, or other | acceptable biometric
or electronic identification process as | approved by the Department.
| (w) "Current usual and customary retail price" means the | price that a pharmacy charges to a non-third-party payor.
| (x) "Automated pharmacy system" means a mechanical system | located within the confines of the pharmacy or remote location | that performs operations or activities, other than compounding | or administration, relative to storage, packaging, dispensing, |
| or distribution of medication, and which collects, controls, | and maintains all transaction information. | (y) "Drug regimen review" means and includes the evaluation | of prescription drug orders and patient records for (1)
known | allergies; (2) drug or potential therapy contraindications;
| (3) reasonable dose, duration of use, and route of | administration, taking into consideration factors such as age, | gender, and contraindications; (4) reasonable directions for | use; (5) potential or actual adverse drug reactions; (6) | drug-drug interactions; (7) drug-food interactions; (8) | drug-disease contraindications; (9) therapeutic duplication; | (10) patient laboratory values when authorized and available; | (11) proper utilization (including over or under utilization) | and optimum therapeutic outcomes; and (12) abuse and misuse.
| (z) "Electronic transmission prescription" means any | prescription order for which a facsimile or electronic image of | the order is electronically transmitted from a licensed | prescriber to a pharmacy. "Electronic transmission | prescription" includes both data and image prescriptions.
| (aa) "Medication therapy management services" means a | distinct service or group of services offered by licensed | pharmacists, physicians licensed to practice medicine in all | its branches, advanced practice nurses authorized in a written | agreement with a physician licensed to practice medicine in all | its branches, or physician assistants authorized in guidelines | by a supervising physician that optimize therapeutic outcomes |
| for individual patients through improved medication use. In a | retail or other non-hospital pharmacy, medication therapy | management services shall consist of the evaluation of | prescription drug orders and patient medication records to | resolve conflicts with the following: | (1) known allergies; | (2) drug or potential therapy contraindications; | (3) reasonable dose, duration of use, and route of | administration, taking into consideration factors such as | age, gender, and contraindications; | (4) reasonable directions for use; | (5) potential or actual adverse drug reactions; | (6) drug-drug interactions; | (7) drug-food interactions; | (8) drug-disease contraindications; | (9) identification of therapeutic duplication; | (10) patient laboratory values when authorized and | available; | (11) proper utilization (including over or under | utilization) and optimum therapeutic outcomes; and | (12) drug abuse and misuse. | "Medication therapy management services" includes the | following: | (1) documenting the services delivered and | communicating the information provided to patients' | prescribers within an appropriate time frame, not to exceed |
| 48 hours; | (2) providing patient counseling designed to enhance a | patient's understanding and the appropriate use of his or | her medications; and | (3) providing information, support services, and | resources designed to enhance a patient's adherence with | his or her prescribed therapeutic regimens.
| "Medication therapy management services" may also include | patient care functions authorized by a physician licensed to | practice medicine in all its branches for his or her identified | patient or groups of patients under specified conditions or | limitations in a standing order from the physician. | "Medication therapy management services" in a licensed | hospital may also include the following: | (1) reviewing assessments of the patient's health | status; and | (2) following protocols of a hospital pharmacy and | therapeutics committee with respect to the fulfillment of | medication orders.
| (bb) "Pharmacist care" means the provision by a pharmacist | of medication therapy management services, with or without the | dispensing of drugs or devices, intended to achieve outcomes | that improve patient health, quality of life, and comfort and | enhance patient safety.
| (cc) "Protected health information" means individually | identifiable health information that, except as otherwise |
| provided, is:
| (1) transmitted by electronic media; | (2) maintained in any medium set forth in the | definition of "electronic media" in the federal Health | Insurance Portability and Accountability Act; or | (3) transmitted or maintained in any other form or | medium. | "Protected health information" does not include individually | identifiable health information found in: | (1) education records covered by the federal Family | Educational Right and Privacy Act; or | (2) employment records held by a licensee in its role | as an employer. | (dd) "Standing order" means a specific order for a patient | or group of patients issued by a physician licensed to practice | medicine in all its branches in Illinois. | (ee) "Address of record" means the address recorded by the | Department in the applicant's or licensee's application file or | license file, as maintained by the Department's licensure | maintenance unit. | (ff) "Home pharmacy" means the location of a pharmacy's | primary operations.
| (Source: P.A. 95-689, eff. 10-29-07; 96-673, eff. 1-1-10.) | (Text of Section after amendment by P.A. 96-339 )
| (Section scheduled to be repealed on January 1, 2018)
|
| Sec. 3. Definitions. For the purpose of this Act, except | where otherwise
limited therein:
| (a) "Pharmacy" or "drugstore" means and includes every | store, shop,
pharmacy department, or other place where | pharmacist
care is
provided
by a pharmacist (1) where drugs, | medicines, or poisons are
dispensed, sold or
offered for sale | at retail, or displayed for sale at retail; or
(2)
where
| prescriptions of physicians, dentists, advanced practice | nurses, physician assistants, veterinarians, podiatrists, or
| optometrists, within the limits of their
licenses, are
| compounded, filled, or dispensed; or (3) which has upon it or
| displayed within
it, or affixed to or used in connection with | it, a sign bearing the word or
words "Pharmacist", "Druggist", | "Pharmacy", "Pharmaceutical
Care", "Apothecary", "Drugstore",
| "Medicine Store", "Prescriptions", "Drugs", "Dispensary", | "Medicines", or any word
or words of similar or like import, | either in the English language
or any other language; or (4) | where the characteristic prescription
sign (Rx) or similar | design is exhibited; or (5) any store, or
shop,
or other place | with respect to which any of the above words, objects,
signs or | designs are used in any advertisement.
| (b) "Drugs" means and includes (l) articles recognized
in | the official United States Pharmacopoeia/National Formulary | (USP/NF),
or any supplement thereto and being intended for and | having for their
main use the diagnosis, cure, mitigation, | treatment or prevention of
disease in man or other animals, as |
| approved by the United States Food and
Drug Administration, but | does not include devices or their components, parts,
or | accessories; and (2) all other articles intended
for and having | for their main use the diagnosis, cure, mitigation,
treatment | or prevention of disease in man or other animals, as approved
| by the United States Food and Drug Administration, but does not | include
devices or their components, parts, or accessories; and | (3) articles
(other than food) having for their main use and | intended
to affect the structure or any function of the body of | man or other
animals; and (4) articles having for their main | use and intended
for use as a component or any articles | specified in clause (l), (2)
or (3); but does not include | devices or their components, parts or
accessories.
| (c) "Medicines" means and includes all drugs intended for
| human or veterinary use approved by the United States Food and | Drug
Administration.
| (d) "Practice of pharmacy" means (1) the interpretation and | the provision of assistance in the monitoring, evaluation, and | implementation of prescription drug orders; (2) the dispensing | of prescription drug orders; (3) participation in drug and | device selection; (4) drug administration limited to the | administration of oral, topical, injectable, and inhalation as | follows: in the context of patient education on the proper use | or delivery of medications; vaccination of patients 14 years of | age and older pursuant to a valid prescription or standing | order, by a physician licensed to practice medicine in all its |
| branches, upon completion of appropriate training, including | how to address contraindications and adverse reactions set | forth by rule, with notification to the patient's physician and | appropriate record retention, or pursuant to hospital pharmacy | and therapeutics committee policies and procedures; (5) drug | regimen review; (6) drug or drug-related research; (7) the | provision of patient counseling; (8) the practice of | telepharmacy; (9) the provision of those acts or services | necessary to provide pharmacist care; (10) medication therapy | management; and (11) the responsibility for compounding and | labeling of drugs and devices (except labeling by a | manufacturer, repackager, or distributor of non-prescription | drugs and commercially packaged legend drugs and devices), | proper and safe storage of drugs and devices, and maintenance | of required records. A pharmacist who performs any of the acts | defined as the practice of pharmacy in this State must be | actively licensed as a pharmacist under this Act.
| (e) "Prescription" means and includes any written, oral, | facsimile, or
electronically transmitted order for drugs
or | medical devices, issued by a physician licensed to practice | medicine in
all its branches, dentist, veterinarian, or | podiatrist, or
optometrist, within the
limits of their | licenses, by a physician assistant in accordance with
| subsection (f) of Section 4, or by an advanced practice nurse | in
accordance with subsection (g) of Section 4, containing the
| following: (l) name
of the patient; (2) date when prescription |
| was issued; (3) name
and strength of drug or description of the | medical device prescribed;
and (4) quantity ; , (5) directions | for use ; , (6) prescriber's name,
address ,
and signature ; , and | (7) DEA number where required, for controlled
substances.
The | prescription may, but is not required to, list the illness, | disease, or condition for which the drug or device is being | prescribed. DEA numbers shall not be required on inpatient drug | orders.
| (f) "Person" means and includes a natural person, | copartnership,
association, corporation, government entity, or | any other legal
entity.
| (g) "Department" means the Department of Financial and
| Professional Regulation.
| (h) "Board of Pharmacy" or "Board" means the State Board
of | Pharmacy of the Department of Financial and Professional | Regulation.
| (i) "Secretary"
means the Secretary
of Financial and | Professional Regulation.
| (j) "Drug product selection" means the interchange for a
| prescribed pharmaceutical product in accordance with Section | 25 of
this Act and Section 3.14 of the Illinois Food, Drug and | Cosmetic Act.
| (k) "Inpatient drug order" means an order issued by an | authorized
prescriber for a resident or patient of a facility | licensed under the
Nursing Home Care Act, the MR/DD Community | Care Act, or the Hospital Licensing Act, or "An Act in relation |
| to
the founding and operation of the University of Illinois | Hospital and the
conduct of University of Illinois health care | programs", approved July 3, 1931,
as amended, or a facility | which is operated by the Department of Human
Services (as | successor to the Department of Mental Health
and Developmental | Disabilities) or the Department of Corrections.
| (k-5) "Pharmacist" means an individual health care | professional and
provider currently licensed by this State to | engage in the practice of
pharmacy.
| (l) "Pharmacist in charge" means the licensed pharmacist | whose name appears
on a pharmacy license and who is responsible | for all aspects of the
operation related to the practice of | pharmacy.
| (m) "Dispense" or "dispensing" means the interpretation, | evaluation, and implementation of a prescription drug order, | including the preparation and delivery of a drug or device to a | patient or patient's agent in a suitable container | appropriately labeled for subsequent administration to or use | by a patient in accordance with applicable State and federal | laws and regulations.
"Dispense" or "dispensing" does not mean | the physical delivery to a patient or a
patient's | representative in a home or institution by a designee of a | pharmacist
or by common carrier. "Dispense" or "dispensing" | also does not mean the physical delivery
of a drug or medical | device to a patient or patient's representative by a
| pharmacist's designee within a pharmacy or drugstore while the |
| pharmacist is
on duty and the pharmacy is open.
| (n) "Nonresident pharmacy"
means a pharmacy that is located | in a state, commonwealth, or territory
of the United States, | other than Illinois, that delivers, dispenses, or
distributes, | through the United States Postal Service, commercially | acceptable parcel delivery service, or other common
carrier, to | Illinois residents, any substance which requires a | prescription.
| (o) "Compounding" means the preparation and mixing of | components, excluding flavorings, (1) as the result of a | prescriber's prescription drug order or initiative based on the | prescriber-patient-pharmacist relationship in the course of | professional practice or (2) for the purpose of, or incident | to, research, teaching, or chemical analysis and not for sale | or dispensing. "Compounding" includes the preparation of drugs | or devices in anticipation of receiving prescription drug | orders based on routine, regularly observed dispensing | patterns. Commercially available products may be compounded | for dispensing to individual patients only if all of the | following conditions are met: (i) the commercial product is not | reasonably available from normal distribution channels in a | timely manner to meet the patient's needs and (ii) the | prescribing practitioner has requested that the drug be | compounded.
| (p) (Blank).
| (q) (Blank).
|
| (r) "Patient counseling" means the communication between a | pharmacist or a student pharmacist under the supervision of a | pharmacist and a patient or the patient's representative about | the patient's medication or device for the purpose of | optimizing proper use of prescription medications or devices. | "Patient counseling" may include without limitation (1) | obtaining a medication history; (2) acquiring a patient's | allergies and health conditions; (3) facilitation of the | patient's understanding of the intended use of the medication; | (4) proper directions for use; (5) significant potential | adverse events; (6) potential food-drug interactions; and (7) | the need to be compliant with the medication therapy. A | pharmacy technician may only participate in the following | aspects of patient counseling under the supervision of a | pharmacist: (1) obtaining medication history; (2) providing | the offer for counseling by a pharmacist or student pharmacist; | and (3) acquiring a patient's allergies and health conditions.
| (s) "Patient profiles" or "patient drug therapy record" | means the
obtaining, recording, and maintenance of patient | prescription
information, including prescriptions for | controlled substances, and
personal information.
| (t) (Blank).
| (u) "Medical device" means an instrument, apparatus, | implement, machine,
contrivance, implant, in vitro reagent, or | other similar or related article,
including any component part | or accessory, required under federal law to
bear the label |
| "Caution: Federal law requires dispensing by or on the order
of | a physician". A seller of goods and services who, only for the | purpose of
retail sales, compounds, sells, rents, or leases | medical devices shall not,
by reasons thereof, be required to | be a licensed pharmacy.
| (v) "Unique identifier" means an electronic signature, | handwritten
signature or initials, thumb print, or other | acceptable biometric
or electronic identification process as | approved by the Department.
| (w) "Current usual and customary retail price" means the | price that a pharmacy charges to a non-third-party payor.
| (x) "Automated pharmacy system" means a mechanical system | located within the confines of the pharmacy or remote location | that performs operations or activities, other than compounding | or administration, relative to storage, packaging, dispensing, | or distribution of medication, and which collects, controls, | and maintains all transaction information. | (y) "Drug regimen review" means and includes the evaluation | of prescription drug orders and patient records for (1)
known | allergies; (2) drug or potential therapy contraindications;
| (3) reasonable dose, duration of use, and route of | administration, taking into consideration factors such as age, | gender, and contraindications; (4) reasonable directions for | use; (5) potential or actual adverse drug reactions; (6) | drug-drug interactions; (7) drug-food interactions; (8) | drug-disease contraindications; (9) therapeutic duplication; |
| (10) patient laboratory values when authorized and available; | (11) proper utilization (including over or under utilization) | and optimum therapeutic outcomes; and (12) abuse and misuse.
| (z) "Electronic transmission prescription" means any | prescription order for which a facsimile or electronic image of | the order is electronically transmitted from a licensed | prescriber to a pharmacy. "Electronic transmission | prescription" includes both data and image prescriptions.
| (aa) "Medication therapy management services" means a | distinct service or group of services offered by licensed | pharmacists, physicians licensed to practice medicine in all | its branches, advanced practice nurses authorized in a written | agreement with a physician licensed to practice medicine in all | its branches, or physician assistants authorized in guidelines | by a supervising physician that optimize therapeutic outcomes | for individual patients through improved medication use. In a | retail or other non-hospital pharmacy, medication therapy | management services shall consist of the evaluation of | prescription drug orders and patient medication records to | resolve conflicts with the following: | (1) known allergies; | (2) drug or potential therapy contraindications; | (3) reasonable dose, duration of use, and route of | administration, taking into consideration factors such as | age, gender, and contraindications; | (4) reasonable directions for use; |
| (5) potential or actual adverse drug reactions; | (6) drug-drug interactions; | (7) drug-food interactions; | (8) drug-disease contraindications; | (9) identification of therapeutic duplication; | (10) patient laboratory values when authorized and | available; | (11) proper utilization (including over or under | utilization) and optimum therapeutic outcomes; and | (12) drug abuse and misuse. | "Medication therapy management services" includes the | following: | (1) documenting the services delivered and | communicating the information provided to patients' | prescribers within an appropriate time frame, not to exceed | 48 hours; | (2) providing patient counseling designed to enhance a | patient's understanding and the appropriate use of his or | her medications; and | (3) providing information, support services, and | resources designed to enhance a patient's adherence with | his or her prescribed therapeutic regimens.
| "Medication therapy management services" may also include | patient care functions authorized by a physician licensed to | practice medicine in all its branches for his or her identified | patient or groups of patients under specified conditions or |
| limitations in a standing order from the physician. | "Medication therapy management services" in a licensed | hospital may also include the following: | (1) reviewing assessments of the patient's health | status; and | (2) following protocols of a hospital pharmacy and | therapeutics committee with respect to the fulfillment of | medication orders.
| (bb) "Pharmacist care" means the provision by a pharmacist | of medication therapy management services, with or without the | dispensing of drugs or devices, intended to achieve outcomes | that improve patient health, quality of life, and comfort and | enhance patient safety.
| (cc) "Protected health information" means individually | identifiable health information that, except as otherwise | provided, is:
| (1) transmitted by electronic media; | (2) maintained in any medium set forth in the | definition of "electronic media" in the federal Health | Insurance Portability and Accountability Act; or | (3) transmitted or maintained in any other form or | medium. | "Protected health information" does not include individually | identifiable health information found in: | (1) education records covered by the federal Family | Educational Right and Privacy Act; or |
| (2) employment records held by a licensee in its role | as an employer. | (dd) "Standing order" means a specific order for a patient | or group of patients issued by a physician licensed to practice | medicine in all its branches in Illinois. | (ee) "Address of record" means the address recorded by the | Department in the applicant's or licensee's application file or | license file, as maintained by the Department's licensure | maintenance unit. | (ff) "Home pharmacy" means the location of a pharmacy's | primary operations.
| (Source: P.A. 95-689, eff. 10-29-07; 96-339, eff. 7-1-10; | 96-673, eff. 1-1-10; revised 10-1-09.)
| Section 99. Effective date. This Act takes effect upon | becoming law.
|
Effective Date: 7/28/2010
|